Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Immunogenicity Is Low and Transient with Intravenous (IV) Abatacept Therapy: Results From a Large Pooled Analysis of 3985 Patients (pts) with Rheumatoid Arthritis (RA) and up to 8 Years' Exposure Weinblatt, M. E., Genovese, M. C., Schiff, M. H., Westhovens, R., Alten, R., Delaet, I., Nys, M., Manning, J., Kremer, J. M. WILEY-BLACKWELL. 2011: S854
View details for Web of Science ID 000297621502577